Literature DB >> 25985577

Ginsenoside Rg3 inhibits lipopolysaccharide-induced adhesion molecule expression in human umbilical vein endothelial cell and C57BL/6 mice.

Young-Suk Cho, Chan Hyung Kim, Han Na Kim, Tae-Sun Ha, Hee Yul Ahn.   

Abstract

Intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), P- and E-selectin play a key role for initiation of vascular inflammation. Ginsenoside, a class of steroid glycosides, is abundant in Panax ginseng root, which has been used for health promotion in Korea. In this study, we investigated the mechanism by which ginsenoside Rg3 may inhibit ICAM-1 and VCAM-1 expressions stimulated with lipopolysaccharide (LPS) in human umbilical vein endothelial cell (HUVEC) and C57BL/6 mice. LPS increased ICAM-1 and VCAM-1 expression. Ginsenoside Rg3 prevented LPS-mediated increase of ICAM-1 and VCAM-1 expression. LPS induced IkappaBα (IκBα) degradation within 1 hr. Ginsenoside Rg3 prevented the IκBα degradation stimulated with LPS. Moreover, ginsenoside Rg3 reduced LPS-mediated THP-1 monocyte adhesion to HUVEC, in a concentration-dependent manner. In C57BL/6 mice, injection of LPS increased aortic ICAM-1 and VCAM-1 expression, which was prevented by ginsenoside Rg3. These data provide a novel mechanism where the ginsenoside Rg3 may provide direct vascular benefits with inhibition of leukocyte adhesion into vascular wall thereby providing prevention against vascular inflammatory disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25985577

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  9 in total

1.  Role of MiR-126a-3p in Endothelial Injury in Endotoxic Mice.

Authors:  Maoping Chu; Shanshan Qin; Rongzhou Wu; Xiangyu Zhou; Xiaojun Tang; Shuo Zhang; Qifeng Zhao; Huating Wang; Ying Liu; Xiaohua Han; Jian Xiao; Xiaokun Li; Chunxiang Zhang
Journal:  Crit Care Med       Date:  2016-08       Impact factor: 7.598

2.  Ginsenoside Rg3 inhibits the biological activity of SGC-7901.

Authors:  Qing Yang; Ning Cai; Daobiao Che; Xing Chen; Dongliang Wang
Journal:  Food Sci Nutr       Date:  2020-06-24       Impact factor: 2.863

3.  Effects of acupuncturing Pishu combined with Ginsenoside Rg3 on the immune function of rats with chronic fatigue.

Authors:  Wenjing Zhang; Yue Zhang; Xiande Ma; Yiguo Chen
Journal:  Int J Clin Exp Med       Date:  2015-10-15

4.  Rg3-enriched Korean Red Ginseng extract inhibits blood-brain barrier disruption in an animal model of multiple sclerosis by modulating expression of NADPH oxidase 2 and 4.

Authors:  Min Jung Lee; Jong Hee Choi; Jinhee Oh; Young Hyun Lee; Jun-Gyo In; Byung-Joon Chang; Seung-Yeol Nah; Ik-Hyun Cho
Journal:  J Ginseng Res       Date:  2020-09-11       Impact factor: 6.060

5.  Anti-adipogenic Effects and Mechanisms of Ginsenoside Rg3 in Pre-adipocytes and Obese Mice.

Authors:  Longyun Zhang; Lijuan Zhang; Xiaoyong Wang; Hongwei Si
Journal:  Front Pharmacol       Date:  2017-03-08       Impact factor: 5.810

6.  Alleviation of diabetic complications by ginsenoside Rg3-enriched red ginseng extract in western diet-fed LDL-/- mice.

Authors:  Evelyn Saba; Seung-Hyung Kim; Sung-Dae Kim; Sang-Joon Park; Dongmi Kwak; Jun-Hwan Oh; Chae-Kyu Park; Man Hee Rhee
Journal:  J Ginseng Res       Date:  2017-04-24       Impact factor: 6.060

7.  How Does Ginsenoside Rh2 Mitigate Adipogenesis in Cultured Cells and Obese Mice?

Authors:  Longyun Zhang; Carlos Virgous; Hongwei Si
Journal:  Molecules       Date:  2020-05-21       Impact factor: 4.411

8.  Anti-Inflammatory Activity of Rg3-Enriched Korean Red Ginseng Extract in Murine Model of Sepsis.

Authors:  Evelyn Saba; Dahye Jeong; Muhammad Irfan; Yuan Yee Lee; Sang-Joon Park; Chae-Kyu Park; Man Hee Rhee
Journal:  Evid Based Complement Alternat Med       Date:  2018-10-11       Impact factor: 2.629

Review 9.  Pharmacological properties, molecular mechanisms and therapeutic potential of ginsenoside Rg3 as an antioxidant and anti-inflammatory agent.

Authors:  Jing Wang; Li Zeng; Ying Zhang; Wenxiu Qi; Ziyuan Wang; Lin Tian; Daqing Zhao; Qibiao Wu; Xiangyan Li; Tan Wang
Journal:  Front Pharmacol       Date:  2022-09-05       Impact factor: 5.988

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.